GILD Archives - Page 3 of 29

3 minute read

FDA Approves Biktarvy Label Update With Data For Pregnant Adults With HIV; Perinatal Guidelines Recognize Biktarvy As Alternative Regimen For Use During Pregnancy And For Those Trying To Conceive

April 26, 8:05 AM

– Additional Data in Pregnant Adults Who Are Virologically Suppressed Reinforce Safety and Tolerability Profile of Biktarvy in Broad Range of People With HIV –– Perinatal Guidelines Recognize Biktarvy as Alternative

GILD

2 minute read

Stocks Drop, Tech Tumbles With Meta’s Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What’s Driving Markets Thursday?

By Piero Cingari

April 25, 1:30 PM

Wall Street suffers a double blow in Thursday’s session, as softer-than-expected revenue forecasts from Meta Platforms Inc. (NASDAQ:META) are being compounded by weaker-than-expected economic growth and higher inflationary pressures last quarter, raising fears of a stagflation phase

AZN

2 minute read

Wall Street’s Most Accurate Analysts’ Views On 3 Health Care Stocks Delivering High-Dividend Yields

By Avi Kapoor

April 25, 7:54 AM

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often…

GILD

4 minute read

US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: ‘Worst Of This Two-Week Decline Is Behind Us,’ Says Analyst

By Shanthi Rexaline

April 25, 6:17 AM

The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platforms, Inc.’s (NASDAQ:META)

AAL

1 minute read

Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?

By Vandana Singh

April 24, 10:31 AM

HOOKIPA Pharma secures FDA clearance for its innovative HB-700 therapeutic vaccine targeting KRAS-mutated cancers. Learn about its broad impact on lung, colorectal, and pancreatic cancers, achieving significant milestones in collaboration and intellectual property.

GILD